Makaleler
5
Tümü (5)
SCI-E, SSCI, AHCI (5)
SCI-E, SSCI, AHCI, ESCI (5)
Scopus (5)
1. Decreased Activity and Genetic Polymorphisms of CYP2C19 in Behcet's Disease
BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY
, cilt.121, sa.4, ss.266-271, 2017 (SCI-Expanded, Scopus)
2. Relationship between genetic polymorphisms of drug efflux transporter MDR1 (ABCB1) and response to losartan in hypertension patients.
European review for medical and pharmacological sciences
, cilt.20, ss.2460-7, 2016 (SCI-Expanded, Scopus)
4. INVESTIGATION OF THE ROLE OF ALLELIC VARIANTS OF MULTIDRUG RESISTANCE GENE (MDR1) ON CLOZAPINE RELATED LEUKOPENIA/AGRANULOCYTOSIS
SCHIZOPHRENIA RESEARCH
, cilt.153, 2014 (SCI-Expanded, SSCI, Scopus)
Hakemli Bilimsel Toplantılarda Yayımlanmış Bildiriler
6
1. ASETAMİNOFEN İLE KARACİĞER HASARI OLUŞTURULAN FARELERDE YAYGIN ENDOTEL DİSFONKSİYONUNUN FARMAKOLOJİK VE HİSTOPATOLOJİK AÇIDAN GÖSTERİLMESİ
24. Ulusal Farmakoloji Kongresi, Türkiye, 17 - 20 Ekim 2017, (Özet Bildiri)
2. Association of multidrug resistance protein 1 MDR1 with drug induced gingival hyperplasia
EPHAR2016, İstanbul, Türkiye, 26 Haziran 2106 - 30 Haziran 2016
3. Association of multidrug resistance protein MDR1 with drug induced gingival hyperplasia
7. EUROPEAN CONGRESS OF PHARMACOLOGY, İstanbul, Türkiye, 26 - 30 Haziran 2016, (Özet Bildiri)
4. Association of eNOS iNOS genetic polymorphisms with drug induced gingival hyperplasia
7. EUROPEAN CONGRESS OF PHARMACOLOGY, 26 - 30 Haziran 2016
5. Endotelyal Nitrik Oksit Sentaz eNOS Genetik Polimorfizmlerinin İlaç Kullanımına Bağlı Dişeti Hipertrofisine Etkisi
23. Ulusal Farmakoloji Kongresi, Türkiye, 7 - 10 Eylül 2015
6. İlaçlara Bağlı Dişeti Hipertrofisine İlaç Taşıyıcı Proteini MDR1 Genetik Polimorfizmlerinin Etkisi
23. Ulusal Farmakoloji Kongresi, Türkiye, 7 - 10 Eylül 2015